Drug-labels.com

Mylan-Indapamide: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
2.5 mg, 1.25 mg
Active ingredient:
ATC code:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - Mylan-Indapamide

ABOUT THIS MEDICATION

What the medication is used for:

MYLAN-INDAPAMIDE is used to treat mild to moderate high blood pressure.

MYLAN-INDAPAMIDE can be used by itself or with other medicines to treat that condition.

What it does:

MYLAN-INDAPAMIDE is a diuretic often called a “water pill”. It increases urination. This lowers blood pressure.

MYLAN-INDAPAMIDE affects the kidney’s ability to reabsorb electrolytes.

This medicine does not cure high blood pressure. It

helps to control it. Therefore, it is important to continue taking MYLAN-INDAPAMIDE regularly even if you feel fine.

When it should not be used:

Do not take MYLAN-INDAPAMIDE if you:

  • Are allergic to indapamide or any other sulfonamide or to any non-medicinal ingredient in the formulation
  • Have severe kidney disease
  • Have severe liver disease or suffer from a condition called hepatic encephalopathy (a degenerative disease of the brain)
  • Have low potassium levels in your blood
  • Are taking drugs to treat heart rhythm disturbances (antiarrhythmics) that might cause severe cardiac arrhythmias
  • Are breastfeeding. MYLAN-INDAPAMIDE passes into breast milk

  • Are pregnant. MYLAN-INDAPAMIDE should not be used during pregnancy. If you become pregnant, discontinue use immediately and discuss with your doctor
  • Have lactose intolerance or have hereditary galactose intolerance, glucose-galactose malabsorption or total lactase deficiency because MYLAN-INDAPAMIDE contains lactose

What the medicinal ingredient is:

Indapamide

What the non-medicinal ingredients are:

Each MYLAN-INDAPAMIDE 1.25 mg tablets:

lactose, microcrystalline cellulose, povidone, starch, talc, sodium starch glycollate, magnesium stearate, hydroxypropyl methylcellulose, polydextrose, polyethylene glycol, titanium dioxide, triacetin, FD&C yellow #6 Aluminium Lake, and D&C yellow #10 Aluminium Lake.

Each MYLAN-INDAPAMIDE 2.5 mg tablets:

lactose, microcrystalline cellulose, povidone, starch, talc, sodium starch glycollate, magnesium stearate, hydroxypropyl methylcellulose, polydextrose, polyethylene glycol, titanium dioxide, triacetin, FD&C red #40 Aluminum Lake, and FD&C blue #2 Aluminum Lake.

What dosage forms it comes in:

Tablets of 1.25 mg or 2.5 mg.

WARNINGS AND PRECAUTIONS

AND PRECAUTIONS

BEFORE you use MYLAN-INDAPAMIDE talk to your doctor, nurse, or pharmacist if you:

  • Are dehydrated or suffer from excessive vomiting, diarrhoea, or sweating
  • Have diabetes, liver or kidney disease
  • Have any congenital or a family history of heart rhythm problems
  • Suffer from hyperparathyroidism (dysfunctioning of the parathyroid gland)
  • Have systemic lupus erythematosus (SLE)
  • Are malnourished
  • Are elderly
  • Have coronary artery disease, heart disease or heart failure
  • Had a surgery called a Sympathectomy
  • Suffer from gout
  • have muscle disorders including muscle pain, tenderness, weakness or cramps,

A decrease in vision or eye pain could indicate the presence of fluid accumulation in the vascular layer of the eye or an increase of pressure in your eye. These manifestations typically occur suddenly within hours to weeks following the taking of MYLAN-INDAPAMIDE. This can lead to permanent vision loss, if not treated. If you have a history of penicillin or sulfonamide allergies, you can be at higher risk of developing these manifestations.

MYLAN-INDAPAMIDE is not recommended for use in children.

You may become sensitive to the sun while taking

MYLAN-INDAPAMIDE. Exposure to sunlight should be minimized.

Athletes should be aware that MYLAN-INDAPAMIDE contains an active ingredient, which may give a positive reaction in doping tests.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to MYLAN-INDAPAMIDE. Dizziness, lightheadedness, or fainting can especially occur after the first dose or when another antihypertensive agent is added.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with MYLAN-INDAPAMIDE:

  • ACTH (e.g. tetracosactide) for treatment of arthritis or inflammatory bowel disease
  • Alcohol, barbiturates (sleeping pills), or narcotics (strong pain medications). They may cause low blood pressure and dizziness when you go from lying or sitting to standing up.

  • Allopurinol (to treat gout)
  • Antibiotics such as moxifloxacin, erythromycin IV, ciprofloxacine, clarithromycin
  • Antifungal medications such as amphotericin B (IV), fluconazole
  • Antimicrobial medications such as pentamidine
  • Baclofen, a skeletal muscle relaxant
  • Calcium tablets or other calcium supplements
  • Ciclosporin, tacrolimus or other medications to depress the immune system after organ transplantation
  • Drugs to treat heart rhythm disturbances (e.g. digoxin, quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, ibutilide, dofetilide, flecainide)
  • Drugs to treat high blood pressure, including angiotensin converting enzyme (ACE) inhibitors
  • Drugs used to treat mental disorders such as anxiety and schizophrenia (e.g. clozapine, risperidone, pimozide, amisulpride, haloperidol, donepezil)
  • Drugs used to treat depression, in particular selective serotonin reuptake inhibitors (SSRIs e.g. paroxetine, sertraline, citalopram, escitalopram) and tricyclic antidepressants (imipramine)
  • Iodinated contrast media
  • Lithium used to treat bipolar disease
  • Metformin, an oral medication for diabetes

    • Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen or celecoxib or high doses of acetylsalicylic acid (more than 3 g/day)
    • Oral corticosteroids for treatment of asthma
    • Potassium-sparing diuretics (e.g. amiloride, spironolactone, triamterene)
    • Stimulant laxatives such as bisacodyl and senna
    • Medicines for the treatment of cancer (e.g. vandetanib, oxaliplatin)
    • Anaesthetics (e.g. propofol, sevoflurane)
    • Anagrelide (used to reduce elevated platelet counts)
    • Medicines used to treat nausea and vomiting (e.g. ondansetron, domperidone)
    • Papaverine (used to treat gastro-intestinal problems)
    • Antiparasitic medicines used to treat certain types of malaria (e.g. chloroquine)
    • Antihistamines used to treat allergic reactions , such as hay fever
    • Methadone (used to treat addiction)

PROPER USE OF THIS MEDICATION

Take MYLAN-INDAPAMIDE exactly as prescribed. It is recommended to take your dose at about the same time every day in the morning. MYLAN-INDAPAMIDE is for oral use: swallow the tablet whole with water.

Usual Adult dose:

1.25 mg tablet a day.

Maximum dose:

2.5 mg a day

Your doctor may increase the dose to a maximum of 2.5 mg daily depending on your response to treatment after 4 to 8 weeks.

Recommended dose for the elderly: 1.25 mg tablet a day.

This dose may be adjusted depending on your kidney function.

Overdose:

If you think you, or a person you are caring for, have taken too much MYLAN-INDAPAMIDE, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

  • Headache
  • Pains in the stomach, back, chest
  • Dizziness
  • Fatigue, weakness
  • Burning or prickling feeling in hands, arms, legs or feet
  • Muscle cramps
  • Vertigo
  • Constipation, diarrhea, nausea, vomiting
  • Cough, dry mouth
  • Swelling
  • Rash, itching

If any of these symptoms affects you severely, tell your doctor, nurse or pharmacist.

MYLAN-INDAPAMIDE can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Common

Electrolyte

disturbances (low levels of sodium,

potassium and/or

chloride): muscle

weakness, pain or cramps, irregular

heartbeat, weakness, generally feeling unwell.

✓

Changes in

heart rate: faster,

slower or irregular

heart beat

✓

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Hyperuricae mia: high uric acid levels in the blood, which may cause gout: pain, swelling and redness in the joints✓

Increased

Blood sugar: frequent urination, thirst, hunger.

✓
Uncommon

Low blood pressure: dizziness, fainting, lightheadednes s.

May occur when you move from lying down or sitting to standing up.

✓
UnknownDecreased White Blood Cells: infections, fatigue, fever, aches, pains and flu-like symptoms.✓

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Eye Disorders:

-Acute Myopia:

sudden near

sightedness or blurred vision.

-Visual impairment

  • Decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye or acute angle-closure glaucoma)
✓

Rhabdomyoly sis:

muscle pain that you cannot explain, muscle

tenderness or weakness, dark brown urine.

✓

Decreased

Platelets: Bruising or unusual bleeding from the skin or other areas,

fatigue, weakness.

✓

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Decreased

Red Blood Cells

(anemia): fatigue,

shortness of breath, irregular

heart rate, dizziness, headache, pale skin.

✓

Liver disorder

yellowing of the skin or eyes, dark

urine, abdominal

pain, nausea,

vomiting, loss of appetite.

✓

Kidney disorder:

change in frequency of urination, nausea,

vomiting, swelling of extremities, fatigue.

✓

Inflammation of the pancreas:

severe upper stomach pain that gets worse when you lie down, often with nausea and vomiting.

✓

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Allergic Reaction/

Angioedema (swelling of the face, lips, mouth,

tongue or throat)

which may cause

difficulty in swallowing or breathing.

✓

Hypercalcaem ia: high calcium levels in the blood, may cause loss of appetite, nausea,

vomiting, constipation, stomach pain.

✓

Torsade de

pointes: life-threatening irregular heart beat

Record of the electrical activity of the heart

(electrocardiog ram

(ECG)) showing a

prolonged QT interval

✓

Possible

worsening

of pre-existing

lupus: a disease

affecting the skin, joints and kidneys

✓

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Hepatitis a liver disease which may

cause nausea, vomiting, loss of appetite, feeling

generally unwell,

fever, itching,

yellowing of

the skin and eyes, light colored bowel motions, dark coloured urine

✓

Severe skin reactions: Stevens

Johnson Syndrome, Toxic

epidermic necrolysis: skin rash, redness of

the skin, blistering of the lips, eyes or mouth, skin peeling, accompanied by fever, chills,

headache, cough, body aches and

generally feeling unwell

✓

This is not a complete list of side effects. For any unexpected effects while taking MYLAN-INDAPAMIDE, contact your doctor, nurse, or pharmacist.

HOW TO STORE IT

Keep out of reach and sight of children.

Store MYLAN-INDAPAMIDE between 15ºC to 30ºC.

Do not use after the expiry date stated on the carton or blister.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about MYLAN-INDAPAMIDE:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website www.mylan.ca, or by calling 1-844-596-9526.

Etobicoke, Ontario M8Z 2S6

Last Revised OCT 08, 2024

Mylan Pharmaceuticals ULC Etobicoke, ON M8Z 2S6 1-844-596-9526 www.mylan.ca

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02153483

Revision date stated in the text: October 8, 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mylan-Indapamide

Rx or OTC
Prescription (Rx)?
DIN 02153483, 02240067
Schedule(s) PRESCRIPTION
Active ingredient(s) Indapamide
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C03 Diuretics
      1. C03B Low-ceiling diuretics, excl. thiazides
        1. C03BA Sulfonamides, low-ceiling diuretics, plain
          1. C03BA11 Indapamide
Company MYLAN PHARMACEUTICALS ULC
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02153483 2.5 MG Tablet Marketed November 16, 2009
02240067 1.25 MG Tablet Marketed November 13, 2009

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.